APOBEC3G anticorps (AA 1-384)
-
- Antigène Voir toutes APOBEC3G Anticorps
- APOBEC3G (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G))
-
Épitope
- AA 1-384
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp APOBEC3G est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human DNA dC->dU-editing enzyme APOBEC-3G protein (1-384AA)
- Isotype
- IgG
- Top Product
- Discover our top product APOBEC3G Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- APOBEC3G (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G))
- Autre désignation
- APOBEC3G (APOBEC3G Produits)
- Synonymes
- anticorps A3G, anticorps ARCD, anticorps ARP-9, anticorps ARP9, anticorps CEM-15, anticorps CEM15, anticorps bK150C2.7, anticorps dJ494G10.1, anticorps apolipoprotein B mRNA editing enzyme catalytic subunit 3G, anticorps APOBEC3G
- Sujet
-
Background: DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. Exhibits potent antiviral activity against vif-deficient HIV-1. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA. The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single-or double-stranded RNA. Exhibits antiviral activity also against simian immunodeficiency viruses (SIVs), hepatitis B virus (HBV), equine infectious anemia virus (EIAV), xenotropic MuLV-related virus (XMRV) and simian foamy virus (SFV). May inhibit the mobility of LTR and non-LTR retrotransposons.
Aliases: A3G antibody, ABC3G_HUMAN antibody, APOBEC related cytidine deaminase antibody, APOBEC related protein antibody, APOBEC-related cytidine deaminase antibody, APOBEC-related protein 9 antibody, APOBEC-related protein antibody, APOBEC3G antibody, Apolipoprotein B editing enzyme catalytic polypeptide like 3G antibody, Apolipoprotein B mRNA editing enzyme catalytic polypeptide 3G antibody, Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 3G antibody, Apolipoprotein B mRNA editing enzyme catalytic subunit 3G antibody, apolipoprotein B mRNA editing enzyme cytidine deaminase antibody, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like antibody, ARCD antibody, ARP-9 antibody, ARP9 antibody, bK150C2.7 antibody, CEM-15 antibody, CEM15 antibody, deoxycytidine deaminase antibody, dJ494G10.1 antibody, DNA dC dU editing enzyme APOBEC 3G antibody, DNA dC->dU editing enzyme antibody, DNA dC->dU-editing enzyme APOBEC-3G antibody, EC 3.5.4. antibody, FLJ12740 antibody, MDS019 antibody, OTTHUMP00000028911 antibody, phorbolin-like protein antibody, phorbolin-like protein MDS019 antibody
- UniProt
- Q9HC16
-